Randomized Comparison of the Abbott WHITESTAR Signature System With Ellips Tranversal Ultrasound vs. the Alcon Infiniti With the Ozil Torsional Handpiece in Phacoemulsification: A Contralaterally-Controlled Trial
1 other identifier
interventional
25
1 country
1
Brief Summary
The purpose of this study is to look at the outcomes of your vision after your cataract surgery based on two different types of equipment that will be used during your surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 14, 2011
CompletedFirst Posted
Study publicly available on registry
January 19, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJanuary 18, 2012
January 1, 2012
3 months
January 14, 2011
January 13, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Visual acuity
1 year
Study Arms (2)
Abbott WHITESTAR Signature System
EXPERIMENTALAbbott WHITESTAR Signature System with Ellips Transversal Ultrasound
Alcon Infiniti
EXPERIMENTALAlcon Infiniti with the OZIL Torsional Handpiece
Interventions
Comparison of vision after cataract surgery based on two different types of equipment.
Comparision of vision after cataract surgery based on two different types of equipment.
Eligibility Criteria
You may qualify if:
- Patients at least 21 scheduled to undergo bilateral phacoemulsification with implantation of multifocal IOLs.
- Both eyes must have similar degrees of cataract and astigmatism (topographic cylinder difference of \<2.00D as well as similar globe axial length as measured by the IOL Master of \<0.5mm).
- Visual potential of UCVA 20/25/ or better.
- Clear intraocular media other than cataract.
You may not qualify if:
- Clinically relevant differences between eyes in ocular disease or pathology.
- Presence of glaucoma, macular disease, or foveal disease to an asymmetrical degree.
- Asymmetrical use of ocular medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kerry Assil
Beverly Hills, California, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 14, 2011
First Posted
January 19, 2011
Study Start
October 1, 2011
Primary Completion
January 1, 2012
Study Completion
January 1, 2012
Last Updated
January 18, 2012
Record last verified: 2012-01